Table 11.
Effects of AADs on sinus node function
| Modified VW class | Drug | Potential for SN depression |
|---|---|---|
| 0 | Ivabradine | Moderate |
| Ia | Quinidine | Milda |
| Procainamide | Mild | |
| Disopyramide | Milda | |
| Ib | Mexiletine/lidocaine | ∼None |
| Ic | Flecainide | Mild to moderateb |
| Propafenone | Mild to moderateb | |
| Id | Ranolazine | ∼None |
| IIa | β-Blockers | Potent |
| IIb | Isoprenaline | ∼None (reverse depression) |
| IIc | Atropine | ∼None (reverse depression) |
| IId | Digitalis | Variable (depends upon autonomic balance; mild direct effect) |
| IIe | Adenosine | Potent |
| III | Amiodarone | Potent |
| Dronedarone | Mild | |
| Dofetilide | ∼None | |
| Ibutilide | ∼None | |
| Sotalol | Potent | |
| Vernakalant | Mild to moderate | |
| IV | Verapamil | Milda |
| Diltiazem | Milda |
Abbreviations: AAD, anti-arrhythmic drug; SN, sinus node.
aAssociated mild vasodilation partially offsets SN depression.
bModerate in patients with SN dysfunction.